Variant transthyretin amyloidosis (ATTRv) is an infiltrative multisystem disorder caused by mutations in the transthyretin (TTR) gene, presenting with cardiac, neurological, or mixed phenotypes. As disease awareness increases, the number of identified mutation carriers is expected to rise. Early diagnosis os ATTRv enables family screening and identification of individuals with subclinical involvement, thereby facilitating the initiation of disease-modifying therapies.

Left atrial strain identifies early cardiac involvement in variant transthyretin amyloidosis

Serenelli, Matteo;Cantone, Anna;Pavasini, Rita;Arzenton, Matteo;Campo, Gianluca;
2026

Abstract

Variant transthyretin amyloidosis (ATTRv) is an infiltrative multisystem disorder caused by mutations in the transthyretin (TTR) gene, presenting with cardiac, neurological, or mixed phenotypes. As disease awareness increases, the number of identified mutation carriers is expected to rise. Early diagnosis os ATTRv enables family screening and identification of individuals with subclinical involvement, thereby facilitating the initiation of disease-modifying therapies.
2026
Serenelli, Matteo; Gardini, Elisa; Marazia, Stefania; Barbarossa, Alessandro; Cipriani, Alberto; Cantone, Anna; Dal Passo, Beatrice; Sanguettoli, Fede...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2643354
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact